Nanobiotix Shares Skyrocket: Cancer Treatment Deal with Big Pharma Nears Finalization
Nanobiotix, a France-based biotechnology company, witnessed a 221.7% increase in its U.S.-listed shares on significant trading volume, following news that the firm has entered into final contract negotiations for the commercialization of its groundbreaking cancer treatment. The company’s trading volume spiked to an astonishing 27.9 million shares, a stark increase from the usual full-day volume […]